baber/WOPTO huggingface dataset:
Patent NZ-574269-A (NZ)
Title: Process for preparation of alkoxylated alkylamines / alkyl ether amines with peaked distribution
Inventor: NGUYEN GIAO VINH
IPC: C07C215/10
Filed: 2007-06-21
Abstract: Disclosed is a process for preparing an alkoxylated alkyl (ether) amine of formula (I) with peaked distribution using a catalyst with a multiple-charge counterion, wherein said process comprises reacting, in a first step, a primary alkylamine with an alkylene oxide at a temperature of from about 150 to about 190 degrees C in order to yield the first intermediate followed by reacting, in a second step, the intermediate with (m) additional molar equivalents of alkylene oxide in the presence of a catalyst with multiple-charge counterions to yield the desired final alkoxylated alkyl (ether) amine product (I) wherein R is selected from a linear or branched, saturated or nonsaturated alkyl group containing 8 - 22 carbon atoms, or is a group of the formula: R'- O - (A)a - (B)b - (C)c - wherein A, B, X, Y are alkylene oxide groups containing 2 - 4 carbon atoms, C is an alkylene group containing 3 - 4 carbon atoms, R' is selected from a linear or branched, saturated or non-saturated alkyl group containing 8 - 22 carbon atoms and the other variables are as disclosed in the description.
Patent NZ-583493-A (NZ)
Title: Structurally weakened culvert end that allows partial collapse of the end on impact loading
Inventor: DAVIS DENNIS
IPC: E01F5/00
Filed: 2010-02-22
Abstract: A culvert end (1) that is structurally weakened in order to allow partial collapse of an upper section of the end on impact loading is disclosed. On impact loading by a vehicle in the event of an accident, the upper section of the culvert end (1) will partially collapse creating a transitioning surface. This will enable the vehicle to override and traverse the culvert safety end (1) and cause transition onto an appropriately graded intersecting road embankment side slope.
Patent NZ-583576-A (NZ)
Title: Octahydropentalene compounds as chemokine receptor antagonists
Inventor: GEORGE DAWN M
IPC: A01N37/18
Filed: 2008-09-25
Abstract: The disclosure relates to 2-aminooctahydropentalene compounds of formula (I), pharmaceutically acceptable salts thereof, pro-drugs thereof, and stereoisomers thereof wherein the variables are as defined in the specification. These compounds of formula (I) are useful as chemokine receptor antagonists and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, rheumatoid arthritis, osteoarthritis, multiple sclerosis and asthma.
Patent NZ-584904-A (NZ)
Title: Displacement device for pivotally held separation elements and article of furniture
Inventor: HAAB GREGOR
IPC: E06B3/50
Filed: 2010-04-26
Abstract: Disclosed is a displacement device with a separation element for an article of furniture or for a building area. The separation element is pivotally connected to a bracket, which is held slideably by a first beam of a scissor assembly and firmly by a second beam of the scissor assembly with a scissor assembly bearing. The displacement device is characterised in that the scissor assembly bearing includes a profile body with a profile which is adapted to the profile of the bracket and connectable thereto. The profile body comprises a profile part that is pivotally connected to a first end of an adjusting lever. A second end of the adjusting lever is pivotally connected to the second beam and is held by an adjusting bolt. The adjusting bolt has a threaded shank which is rotatably mounted in a threaded channel of the profile body.
Patent NZ-586392-A (NZ)
Title: Arrangement and method for improving throughput in a rotary milking system where the animals enter the platform based on the expected action time for each animal
Inventor: LINDSTROM KRISTER
IPC: A01K1/12
Filed: 2009-01-16
Abstract: An arrangement for improving the throughput of milking animals in a rotary milking system 1 comprises a rotary platform 3, which milking animals enter and leave in a sequential order in order to be milked. The arrangement comprises identifying means arranged to identify a plurality of milking animals to be milked by the rotary milking system 1, retrieving means arranged to retrieve a measure indicative of the expected time required for performing at least one action on the rotary platform 3 with respect to each of the milking animals, and guiding means arranged to allow the milking animals to enter the rotary platform 3 of the rotary milking system 1 in an order, which is based on the measures indicative of the expected times required for performing the at least one action on the rotary platform 3 with respect to the milking animals.
Patent NZ-591162-A (NZ)
Title: cutting device using rolls and conveyors and method for using such to produce an absorbent article
Inventor: YAMAMOTO HIROKI
IPC: B31B50/20
Filed: 2009-08-07
Abstract: 591162 Disclosed is a cutting device (100) which conveys a web between a die roll (10) and an anvil roll (20), and cuts continuous sections of the web. The cutting device is provided with a continuous section conveying means (30) which immobilizes and conveys the continuous sections, and a non-continuous section conveying means (40) which immobilizes and conveys non-continuous sections. The die roll has a first large-diameter component (12) with a cutting blade (15) provided on the circumferential surface thereof for cutting the continuous sections. The anvil roll has a second large-diameter component (22) facing the first large-diameter component. The continuous section conveying means supplies the continuous sections to a pressure-contact region (T). The non-continuous section conveying means causes the non-continuous sections to pass through the die roll and the anvil roll without making contact therewith.
Patent NZ-593438-A (NZ)
Title: Synthesis of polymer conjugates of indolocarbazole compounds
Inventor: BAGNOD RAFFAELLA
IPC: A61K47/48
Filed: 2009-12-22
Abstract: Disclosed is a process for the preparation of a polymer conjugate of an indolocarbazole compound of formula (I), wherein the substituents are as described within the specification, whereby the process comprises reacting a w-1H-imidazole-carboxamide with an indolocarbazole compound of formula (III). Further disclosed is a polymer conjugate of a compound of formula (I), a pharmaceutical composition comprising said polymer conjugate, and the use of said polymer conjugate in the manufacture of a medicament for the prevention, alleviation or/and treatment of HMGB-1 associated pathologies, such as atherosclerosis, tumours and neurodegenerative diseases.
Patent NZ-595263-A (NZ)
Title: Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
Inventor: BHAT LAXMINARAYAN
IPC: A61K31/497
Filed: 2010-02-26
Abstract: 595263 Disclosed herein are arylpiperazine derivatives of the formula 1, wherein the variable are defined herein, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression. Specific embodiments of the compound include: 6-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one hydrochloride, 4-(4-(2-methoxyphenyl)piperazin-1-yl)-N-(3-oxo-3,4-dihydro-2H-benzo[b][I,4]oxazin-6-yl)butanamide, and 6-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one.
Patent NZ-597694-A (NZ)
Title: Anti-IGF antibodies
Inventor: ADAM PAUL
IPC: A61K33/243
Filed: 2009-12-11
Abstract: NZ 597694 Disclosed is an isolated human antibody molecule, as defined in the complete specification. The disclosed antibody: binds to mouse and rat IGF-1 and IGF-2; does not bind to human insulin; and binds to human IGF-1 and IGF-2 such that: binding of IGF-1 and IGF-2 to the IGF-1 receptor is prevented; and IGF-1 receptor-mediated signalling is inhibited. The disclosed antibody is used in the treatment of cancer.
Patent NZ-602194-A (NZ)
Title: Storage of respiratory produce
Inventor: VERBOVEN PIETER
IPC: A23L3/3418
Filed: 2011-03-17
Abstract: Disclosed is a control system for controlling the storage of respiratory produce in a defined confined storage environment (1). The control system includes at least one gas analysing means (2) with a control unit (20) for determining an adjusted gas medium composition of the confined storage environment (1) for protecting the produce against fermentative degradation. At least one operating/actuating means adapts the gas medium in the confined storage environment based on the determined adjusted gas medium composition. The control unit (20) determines the adjusted gas medium composition based on a mathematical model of the system. The model is used to determine the actual respiratory and fermentative rates of the produce on the evaluation of the gas exchange dynamics of the storage system with the gas exchange dynamics of the respiratory produce. The adjusted gas medium composition is determined as a function of the calculated total gas exchange rate quotient (GERQ) in the confined storage environment.
Patent NZ-602403-A (NZ)
Title: Bin lid and bin incorporating same
Inventor: STONE WARREN LEONARD
IPC: B65F1/16
Filed: 2011-04-05
Abstract: A lid 101 for a bin 110, an end of the lid 101 being configured for pivotal engagement with an open top of the bin 110, where the lid 101 is pivotable between an open position in which it is substantially clear of the open top to permit emptying of the bin 110 by inversion of the bin 110 and a closed position, in which the lid 101 covers the open top. The lid 101 comprises a closure which is movable across an opening defined through the lid 101. The closure is moveable between an open condition, in which it permits waste to be placed into the receptacle through the opening at the end of the lid 101 being configured for pivotal engagement, and a closed condition, in which the lid 101 covers the opening. The closure is openable at the end of the lid 101 configured for pivotal engagement, and comprises a shutter 108.
Patent NZ-613839-A (NZ)
Title: Transport and presentation box
Inventor: ORGELDINGER WOLFGANG
IPC: B65D85/30
Filed: 2011-02-10
Abstract: 613839 A box comprises a bottom and at least two pairs of side walls which in each case lie opposite one another, wherein a first one of the side walls (16b) extends upwards at least partially from the bottom in a vertical direction only by a removal height which is smaller than the height of one or more of the remaining side walls, in order to define a lateral opening with a dimension which makes access to and removal of products contained in the box possible through the lateral opening. Furthermore, the box comprises an insert for arrangement on the bottom (12), wherein the insert is designed in a manner dependent on the products which are to be accommodated by the box. Furthermore, the box comprises a blocking element and a locking mechanism for locking the blocking element in a first, closed position.
Patent NZ-615224-A (NZ)
Title: Process for obtaining a constituent from whey protein concentrate
Inventor: LEHMANN HANNO
IPC: A23J1/20
Filed: 2012-03-07
Abstract: A process for obtaining a constituent, such as whey protein isolate, from whey protein concentrate by microfiltration. Retentate is fed to a microfiltration arrangement (4) where at a first stage (see 5.1, figures 2(a) & 2(b)) the retentate stream is separated into a first fat enriched substream (see 255, figure 2(b)) and a first fat depleted substream (see 256, figure 2(b)). The first fat depleted substream is then fed to a second stage (see 5.2, figures 2(a) & 2(b)) where the first fat depleted substream is further separated into a second fat enriched substream and a second fat depleted substream. A recirculated substream (see 14, figure 2(b)) is then fed from the second or both the first and second fat depleted substreams back to the microfiltration arrangement. The two stage separation process, followed by recirculation of the fat depleted retentate, advantageously enhances the quality and yield of the end constituent.
Patent NZ-616554-A (NZ)
Title: Compositions for the treatment of neurologic disorders
Inventor: PANTZARIS MARIOS
IPC: A61P43/00
Filed: 2012-03-28
Abstract: Disclosed are compositions comprising docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), linoleic acid (LA), gamma linolenic add (GLA), and other omega-3 polyunsaturated fatty acids (PUFAs), monounsaturated fatty acids (MUFAs), and saturated fatty acids (SFAs). Also disclosed are compositions further comprising gamma tocopherol, Vitamin A, and Vitamin E. The compositions are useful for treating neurologic disorders. The compositions are administered chronically for the prevention and/or treatment of multiple sclerosis (MS) and other degenerative diseases.
Patent NZ-618244-A (NZ)
Title: Financial management system
Inventor: SALTER GEOFF
IPC: G06Q40/06
Filed: 2012-05-03
Abstract: A system for constructing an investment portfolio for an investor and a method of managing an investment portfolio of an investor are disclosed. The system comprises (a) a computer system and computer readable data storage in communication with the computer system. The computer readable data storage includes computer readable instructions stored thereon which, when executed, cause the computer system to perform the steps of (i) receiving risk tolerance data representing the risk tolerance level of the investor; (ii) receiving data representing selection criteria from the user terminal, (iv) generating, for display on the user interface of the user terminal, a list of investments for inclusion in the portfolio, where the investments are ranked in accordance with the selection criteria; (vi) receiving, from the user terminal, data representing a selection of investments from the list of investments for inclusion in the portfolio; and (vii) generating, for display on the user interface of the user terminal, a table showing each investment of the selection of investments; a distribution of investor assets over one or more asset classes of each investment; a distribution of assets over one or more asset classes of a benchmark risk category representing a risk tolerance level of the investor; and a distribution of assets over the one or more asset classes for the entire investment portfolio
Patent NZ-621374-A (NZ)
Title: Safety apparatus and valve connection apparatus
Inventor: COLIN WILLIAM HUTCHINSON
IPC: E04G21/32
Filed: 2013-02-18
Abstract: The use of a safety bag valve connection apparatus (30) for connecting together inflatable safety bags used to soften the impact of a person or object. The apparatus (30) has a first flange member (31) for connecting to a first safety bag which flange (31) defines a first opening. A second flange member (32) connects to a second safety bag, the second flange member (32) defining a second opening. Longitudinally collapsible conduit means (35) are connected between the first (31) and second (32) flange members and define a conduit fluidly connecting the first and second openings.
Patent NZ-628927-A (NZ)
Title: Compounds and methods for treating candidiasis and aspergillus infections
Inventor: SCOTT RICHARD W
IPC: C07D239/24
Filed: 2013-01-18
Abstract: Disclosed is the use of compounds of formula IV in the manufacture of a medicament for killing or inhibiting the growth of a Candida or Aspergillus species or preventing or treating a mammal having oral or disseminated candidiasis or an aspergillus infection, wherein the substituents are as defined in the specification.
Patent NZ-719783-A (NZ)
Title: Long-acting ketoprofen compositions
Inventor: MACHKOVECH SUSAN M
IPC: A61K47/44
Filed: 2014-12-15
Abstract: The invention describes a long-acting veterinary composition comprising at least one ketoprofen ester prodrug. The composition also comprises at least one veterinary acceptable triglyceride, and optionally, at least one preservative, and optionally, at least one additional veterinary acceptable excipient. The invention also describes a method of treating an animal for fever, pain, and/or inflammation by administering the long-acting composition comprising at least one ketoprofen ester prodrug to the animal in need thereof.
Patent NZ-727849-A (NZ)
Title: Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Inventor: SONI PARESH
IPC: A61P9/10
Filed: 2013-06-28
Abstract: The invention relates to the use of eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid in the manufacture of a medicament for reducing a risk of a cardiovascular event selected from the group consisting of cardiovascular death, coronary revascularization, and/or unstable angina in a subject on stable statin therapy, wherein: (a) the subject has previously been identified as having dyslipidemia, as being on stable statin therapy and as having a fasting baseline triglyceride level of about 135 mg/dL to about 500 mg/dL, optionally wherein said subject has established cardiovascular disease or has a high risk of developing cardiovascular disease; and (b) the medicament is formulated for daily administration to provide about 4 g of the eicosapentaenoic acid per day. The invention also relates to the use of eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid in the manufacture of a medicament for reducing a risk of a cardiovascular event in a subject on statin therapy (a) with residual atherogenic dyslipidemia and clinically evident cardiovascular disease or (b) without clinically evident cardiovascular disease but with increased risk of cardiovascular disease, wherein: (a) the medicament is formulated for daily administration for a period of at least about 2 years of about 4g of eicosapentaenoic acid; and (b) the use reduces risk of cardiovascular disease, need for coronary revascularization, risk of unstable angina, risk for stroke, risk for myocardial infarction, or any combination thereof.
Patent NZ-730559-A (NZ)
Title: Dynamic system resonant frequency detection and compensation methods for wpt and relevant technologies -soft-switching converters and capacitors
Inventor: JIANLONG TIAN
IPC: H02M7/539
Filed: 2016-04-06
Abstract: A switch mode DC-AC converter driven oscillation system which always works on square wave driving, soft-switching and resonant conditions supported by the following four techniques is disclosed. ① the techniques composed of totally analog circuitry to dynamically detect the innate resonant frequency of the system through comparison between the phases of the gate driving and zero voltage or current crossing signals of the main oscillation of the system and to drive the system with the detected innate resonant frequency to realize resonant operation and soft-switching. Based on different types of PLL technologies, two of such techniques are disclosed. ② the technique to realize a Voltage Controlled Soft-switching Capacitor (VCSC) to compensate the innate resonant frequency or to adjust the output voltage or power of the system through its tuning/detuning effect; ③ the technique to avoid frequency bifurcation through limiting the output frequency range of the VCO by selecting values for the external resistors and/or capacitors of the VCO, and/or by limiting the input voltage range of the VCO through voltage dividers formed by resistors; ④ the technique to adjust the output pulse width of mono-stable flip flops dynamically with a DC voltage. All of the above techniques are realized through analog circuits without employing any digital components such as micro-controllers, DSPs, FPGAs, analog-digital converters, etc. so that the circuit reflects and adjusts to errors much quicker than those employing digital components.
Patent NZ-735053-A (NZ)
Title: A system, power outlet and power plug for selectively providing power for validly tagged electrical appliances
Inventor: GINN ALEXANDER
IPC: G01R1/04
Filed: 2016-01-28
Abstract: A system for industrial electrical appliance tagging and compliance system is provided, comprising at least one power outlets for selectively providing power for validly tagged electrical appliance based on whether an expiry date is post, wherein the expiry date is calculated according to a validity period stored in a power outlet and the inspection date stored in a plug. In use, when the at least one electrical appliance power plug is plugged into the at least one power outlet, the power controller of the at least one power outlet is configured to: read, using the data bearing media reader, the inspection date from the data bearing media of the at least one electrical appliance power plug; read the validity period from the power controller memory; calculate an expiry date in accordance with the validity period and the inspection date; determine a current date; close the switch if the calculated expiry date is prior the current date; and open the switch if the calculated expiry date is post the current date.
Patent NZ-744440-A (NZ)
Title: Mask system
Inventor: SCHEINER RUPERT
IPC: A61M16/06
Filed: 2010-09-10
Abstract: A CPAP mask system including a cushion adapted to seal with a face of a patient is disclosed.The mask system provides respiratory therapy to the airways of a patient. The mask system includes: a frame, wherein the frame has a main body and a forehead support extending from a top end of the main body, the forehead support including at least one upper headgear connector, and wherein the main body includes a lower headgear connector. The mask also includes a cushion configured to interface with the frame, wherein the cushion includes a non face-contacting side and a face-contacting side having a membrane. The face-contacting side has a nasal bridge region configured to form a seal with a nasal bridge region of the patient’s face. The face-contacting side has a lip region and the cushion has a side-of-nose region configured to form a seal with a side-of-nose region of the patient’s face. The cushion includes a thin section in the nasal bridge region between the face-contacting side and non-face contacting side, and a flexible backup band positioned to provide support to the face contacting side at the nasal bridge region of the cushion and configured to extend down from the nasal-bridge-region to at least a portion of the side-of-nose region of the cushion. The cushion is substantially unsupported in the lip region.
Patent NZ-767004-A (NZ)
Title: Solid inspection apparatus and method of use
Inventor: EARNEY JOHN GERHARDT
IPC: G01N21/64
Filed: 2017-12-11
Abstract: An optical detection device, may comprise: an optical target including a solid body that encloses a fluorescing material; an objective to direct excitation light toward the optical target and to receive fluorescence emission from the optical target; a driver to move the objective to a region of interest proximate to the optical target; memory to store program instructions; and a processor to execute the program instructions for detecting fluorescence emission from the optical target in connection with at least one of optical alignment or calibration of an instrument.
Patent NZ-776080-A (NZ)
Title: Modified rnai agents
Inventor: MANOHARAN MUTHIAH
IPC: A61K31/713
Filed: 2012-11-16
Abstract: Disclosed is a double-stranded RNAi (dsRNA) duplex agent capable of inhibiting the expression of a target gene. The dsRNA duplex comprises one or more motifs of three identical modifications on three consecutive nucleotides in one or both strand, particularly at or near the cleavage site of the strand. Other aspects of the invention relates to pharmaceutical compositions comprising these dsRNA agents and the use of such dsRNA agents in the manufacture of a medicament for delivering a polynucleotide to a specific target in a subject.
Patent PT-100352-A (PT)
Inventor: GANDOLFI CARMELO A
IPC: C07D403/14
Filed: 1992-04-07
Abstract: PCT No. PCT/EP92/00724 Sec. 371 Date Sep. 27, 1993 Sec. 102(e) Date Sep. 27, 1993 PCT Filed Apr. 1, 1992 PCT Pub. No. WO92/18478 PCT Pub. Date Oct. 29, 1992.Compounds of the formula   <IMAGE>   wherein A, Y, X, B and D are described in the specification are disclosed. The compounds possess activity in treating asthma and other pathologies of the respiratory tract.